Literature DB >> 6423829

Waldenström's macroglobulinemia: report of a case with pulmonary involvement and recurrent pneumococcal sepsis after pneumococcal vaccination.

T E King, M I Schwarz, M Mathew.   

Abstract

A patient with Waldenström's macroglobulinemia who presented with pleuropulmonary manifestations is described. The course was complicated by recurrent Streptococcus pneumoniae infections despite pneumococcal immunization.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6423829      PMCID： PMC2561739     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  13 in total

1.  Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.

Authors:  J M Borgoño; A A McLean; P P Vella; A F Woodhour; I Canepa; W L Davidson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

Review 2.  Reassessment of the source, mode and locus of action of antidiuretic hormone.

Authors:  K G Wakim
Journal:  Am J Med       Date:  1967-03       Impact factor: 4.965

3.  Efficacy of pneumococcal polysaccharide vaccines.

Authors:  C V Broome
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

4.  Pleuropulmonary manifestations of Waldenstrom's macroglobulinemia.

Authors:  R H Winterbauer; R C Riggins; F A Griesman; D E Bauermeister
Journal:  Chest       Date:  1974-10       Impact factor: 9.410

5.  Pneumococcal vaccination: the response of patients with multiple myeloma.

Authors:  H M Lazarus; M Lederman; A Lubin; R H Herzig; G Schiffman; P Jones; A Wine; H M Rodman
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

6.  Macroglobulinemia: an analysis for forty patients.

Authors:  M R MacKenzie; H H Fudenberg
Journal:  Blood       Date:  1972-06       Impact factor: 22.113

7.  Pneumococcal vaccine in the United States. A critical analysis.

Authors:  J V Hirschmann; B A Lipsky
Journal:  JAMA       Date:  1981-09-25       Impact factor: 56.272

Review 8.  Assessment of the antibody response to pneumococcal vaccine in high-risk populations.

Authors:  S H Landesman; G Schiffman
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

9.  Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.

Authors:  C V Broome; R R Facklam; D W Fraser
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245

10.  Pulmonary manifestations of Waldenstrom macroglobulinemia.

Authors:  P G Rausch; J C Herion
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.